CA2358891A1 - Thienylbenzoylbenzazepines utilisees en tant qu'agonistes de la vasopressine - Google Patents
Thienylbenzoylbenzazepines utilisees en tant qu'agonistes de la vasopressine Download PDFInfo
- Publication number
- CA2358891A1 CA2358891A1 CA002358891A CA2358891A CA2358891A1 CA 2358891 A1 CA2358891 A1 CA 2358891A1 CA 002358891 A CA002358891 A CA 002358891A CA 2358891 A CA2358891 A CA 2358891A CA 2358891 A1 CA2358891 A1 CA 2358891A1
- Authority
- CA
- Canada
- Prior art keywords
- chloro
- methanone
- benzodiazepin
- phenyl
- dihydro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La présente invention se rapporte à des composés représentés par la formule générale (I) dans laquelle Y est une fraction sélectionnée indépendamment parmi NH ou (CH¿2?)¿n?, où n est égal à 1; m est un entier égal à 1 ou 2 et la fraction (a) représente (1) un noyau hétérocyclique aromatique (insaturé) à 5 éléments comportant un atome d'azote (dans lequel A est azote, et B et C sont CH), (2) un noyau hétérocyclique aromatique (insaturé) à 6 éléments comportant un atome d'azote (dans lequel A est carbone, B est azote, et C est CH-CH-), (3) un noyau aromatique (insaturé) à 6 éléments (dans lequel A est carbone, B est CH et C est CH-CH-). L'invention se rapporte également à des méthodes et à des compositions pharmaceutiques utilisant ces composés pour le traitement des troubles qui peuvent être soignés ou soulagés par une activité agoniste de la vasopressine, notamment le diabète insipide, l'énurésie nocturne, la polyurie nocturne, l'incontinence urinaire, les troubles de saignement et de coagulation ou le retard temporaire de la miction.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US24417999A | 1999-02-04 | 1999-02-04 | |
US09/244,179 | 1999-02-04 | ||
PCT/US2000/000358 WO2000046227A1 (fr) | 1999-02-04 | 2000-01-07 | Thienylbenzoylbenzazepines utilisees en tant qu'agonistes de la vasopressine |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2358891A1 true CA2358891A1 (fr) | 2000-08-10 |
Family
ID=22921681
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002358891A Abandoned CA2358891A1 (fr) | 1999-02-04 | 2000-01-07 | Thienylbenzoylbenzazepines utilisees en tant qu'agonistes de la vasopressine |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1149103A1 (fr) |
JP (1) | JP2002536377A (fr) |
CN (1) | CN1339036A (fr) |
AR (1) | AR028470A1 (fr) |
AU (1) | AU2603000A (fr) |
CA (1) | CA2358891A1 (fr) |
WO (1) | WO2000046227A1 (fr) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1391476A (zh) * | 1999-09-27 | 2003-01-15 | 美国氰胺公司 | 血管升压素激动剂制剂和方法 |
MXPA03009158A (es) * | 2001-04-12 | 2004-02-12 | Wyeth Corp | Azepinas y diazepinas bi y triciclicas substituidas de n-bifenilcarbonil y n-fenilpiridilcarbonil como agonistas de la vasopresion. |
GB201005623D0 (en) | 2010-04-01 | 2010-05-19 | Vantia Ltd | New polymorph |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5521173A (en) * | 1995-01-17 | 1996-05-28 | American Home Products Corporation | Tricyclic benzazepine vasopressin antagonists |
US5849735A (en) * | 1995-01-17 | 1998-12-15 | American Cyanamid Company | Tricyclic benzazepine vasopressin antagonists |
-
2000
- 2000-01-07 CA CA002358891A patent/CA2358891A1/fr not_active Abandoned
- 2000-01-07 WO PCT/US2000/000358 patent/WO2000046227A1/fr active Application Filing
- 2000-01-07 JP JP2000597297A patent/JP2002536377A/ja active Pending
- 2000-01-07 AU AU26030/00A patent/AU2603000A/en not_active Abandoned
- 2000-01-07 EP EP00904244A patent/EP1149103A1/fr not_active Withdrawn
- 2000-01-07 CN CN00803456A patent/CN1339036A/zh active Pending
- 2000-02-03 AR ARP000100462A patent/AR028470A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
CN1339036A (zh) | 2002-03-06 |
EP1149103A1 (fr) | 2001-10-31 |
JP2002536377A (ja) | 2002-10-29 |
WO2000046227A1 (fr) | 2000-08-10 |
AU2603000A (en) | 2000-08-25 |
AR028470A1 (es) | 2003-05-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6194407B1 (en) | Tricyclic pyrido vasopressin agonists | |
US7465722B2 (en) | Biphenyl vasopressin agonists | |
US6090803A (en) | Tricyclic vasopressin agonists | |
US7329653B2 (en) | Cyclohexylphenyl vasopressin agonists | |
US6268360B1 (en) | 1H-pyrido[2,3-b][1,5]benzodiazipine vasopressin agonists | |
US6344451B1 (en) | Pyrrolobenzodiazepine carboxyamide vasopressin agonists | |
EP1000059B1 (fr) | Agonistes tricycliques de la vasopressine | |
US6235900B1 (en) | Tricyclic pyridine N-oxides vasopressin agonists | |
US6620807B1 (en) | Pyridobenzodiazepine and pyridobenzoxazepine carboxyamide vasopressin agonists | |
EP1149096B1 (fr) | N-oxydes de pyridine tricyclique en tant qu'agonistes de la vasopressine | |
CA2358891A1 (fr) | Thienylbenzoylbenzazepines utilisees en tant qu'agonistes de la vasopressine | |
EP1149104B1 (fr) | Pyrrolobenzodiazepine carboxyamide en tant qu'agonistes de la vasopressine | |
CA2358895A1 (fr) | Pyridobenzodiazepine et pyridobenzoxazepine carboxyamide en tant qu'agonistes de la vasopressine | |
MXPA01007916A (en) | Thienylbenzoylbenzazepines as vasopressin agonists | |
MXPA01007918A (en) | Pyridobenzodiazepine and pyridobenzoxazepine carboxyamide vasopressin agonists | |
MXPA01007919A (es) | Agonistas de vasopresina de carboxiamidas pirrolobenzodiazepinas | |
MXPA00000749A (en) | Tricyclic vasopressin agonists |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |